Alternatives to Verge Genomics

AI foundation models predicting patient drug response to de-risk clinical trials

AI drug discovery engine pairing 2M weekly wet-lab experiments with a 50+ petabyte phenomics dataset

Tech-driven drug discovery and biologics manufacturing platform

Generative AI drug discovery platform spanning target ID to clinical trials, with its own Phase III pipeline as proof.

Generative AI and robotics platform compressing drug discovery to under two years.

Physics-based molecular discovery platform for drug and materials design

BenevolentAI: AI drug discovery knowledge graph for target discovery and repurposing

AI-native drug discovery platform turning 50PB+ cellular imaging into clinical-stage therapies

AI-driven drug discovery platform with 50+PB proprietary data and automated wet labs

AI co-scientist for biomedical research: multi-omics, drug discovery, and lab protocol reasoning

AI-driven CRISPR platform revealing causal disease-driving RNA pathways for immunology and oncology drug discovery

Open-source AI research assistant for accelerated drug discovery, self-hosted with full data control

Silico: mechanistic interpretability platform to understand, debug, and design AI models

Nimbus Therapeutics designs highly selective small-molecule drugs for oncology, immunology, and metabolic disease.

Cloud ELN, LIMS, and AI platform that unifies biotech R&D data for discovery teams.

FDA-cleared AI for cancer pathology diagnostics and biomarker discovery.

AI-powered precision oncology platform analyzing clinical and molecular data for personalized cancer care.

Causal AI for human health, turning 20+ petabytes of cellular data into targeted therapeutics.

AI cell therapy manufacturing with laser precision and closed-loop control

PathAI is an enterprise AI pathology platform for diagnostic accuracy and biopharma drug development.

AI target discovery for neurotherapeutics targeting neural circuits across disorders

AI-designed multivalent nanoparticles for cell-selective drug delivery

Owkin's K Pro: an autonomous AI scientist for biopharma R&D decision-making

Oncology real-world evidence platform that turns patient data into AI-powered cancer research insights.

AI-driven clinical trial patient matching and recruitment from EMR data.

Quibim turns MRI, CT, and PET scans into regulatory-cleared quantitative imaging biomarkers for radiology and biopharma

ML-guided protein engineering platform to co-optimize multiple properties with your own experimental data

Causal AI drug discovery models that predict how biology responds to perturbation, from target to patient.

Dotmatics Luma Agent: agentic AI for multimodal R&D data analysis and scientific workflow automation

Adaptyv runs automated protein binding, expression, and thermostability assays as fast as 3 days.